Esquela‐Kerscher, A, Slack, FJ. Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259–269.
Ma, L. Role of miR‐10b in breast cancer metastasis. Breast Cancer Res 2010, 12:210.
Dong, Z, Zhong, Z, Yang, L, Wang, S, Gong, Z. MicroRNA‐31 inhibits cisplatin‐induced apoptosis in non‐small cell lung cancer cells by regulating the drug transporter ABCB9. Cancer Lett 2014, 343:249–257.
Zhao, B, Han, H, Chen, J, Zhang, Z, Li, S, Fang, F, Zheng, Q, Ma, Y, Zhang, J, Wu, N, et al. MicroRNA let‐7c inhibits migration and invasion of human non‐small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett 2014, 342:43–51.
Chen, J, Wang, X. MicroRNA‐21 in breast cancer: diagnostic and prognostic potential. Clin Transl Oncol 2014, 16:225–233.
Qin, J, Luo, M. MicroRNA‐221 promotes colorectal cancer cell invasion and metastasis by targeting RECK. FEBS Lett 2014, 588:99–104.
Chen, Z, Ma, T, Huang, C, Zhang, L, Xu, T, Hu, T, Li, J. MicroRNA‐148a: a potential therapeutic target for cancer. Gene 2014, 533:456–457.
Shin, JI, Brusselle, GG. Mechanistic links between COPD and lung cancer: a role of microRNA let7? Nat Rev Cancer 2014, 14:70.
Asangani, IA, Rasheed, SA, Nikolova, DA, Leupold, JH, Colburn, NH, Post, S, Allgayer, H. MicroRNA‐21 (miR‐21) post‐transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128–2136.
Lei, R, Tang, J, Zhuang, X, Deng, R, Li, G, Yu, J, Liang, Y, Xiao, J, Wang, HY, Yang, Q, et al. Suppression of MIM by microRNA‐182 activates RhoA and promotes breast cancer metastasis. Oncogene 2014, 33:1287–1296.
Li, T, Lu, YY, Zhao, XD, Guo, HQ, Liu, CH, Li, H, Zhou, L, Han, YN, Wu, KC, Nie, YZ, et al. MicroRNA‐296‐5p increases proliferation in gastric cancer through repression of Caudal‐related homeobox 1. Oncogene 2014, 33:783–793.
Li, BS, Zhao, YL, Guo, G, Li, W, Zhu, ED, Luo, X, Mao, XH, Zou, QM, Yu, PW, Zuo, QF, et al. Plasma microRNAs, miR‐223, miR‐21 and miR‐218, as novel potential biomarkers for gastric cancer detection. PLoS One 2012, 7:e41629.
Yang, X, Zeng, Z, Hou, Y, Yuan, T, Gao, C, Jia, W, Yi, X, Liu, M. MicroRNA‐92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta‐analysis. PLoS One 2014, 9:e88745.
Jang, K, Ahn, H, Sim, J, Han, H, Abdul, R, Paik, SS, Chung, MS, Jang, SJ. Loss of microRNA‐200a expression correlates with tumor progression in breast cancer. Transl Res 2014, 163:242–251.
Ma, L, Reinhardt, F, Pan, E, Soutschek, J, Bhat, B, Marcusson, EG, Teruya‐Feldstein, J, Bell, GW, Weinberg, RA. Therapeutic silencing of miR‐10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010, 28:341–347.
Medina, PP, Nolde, M, Slack, FJ. OncomiR addiction in an in vivo model of microRNA‐21‐induced pre‐B‐cell lymphoma. Nature 2010, 467:86–90.
Yigit, MV, Ghosh, SK, Kumar, M, Petkova, V, Kavishwar, A, Moore, A, Medarova, Z. Context‐dependent differences in miR‐10b breast oncogenesis can be targeted for the prevention and arrest of lymph node metastasis. Oncogene 2013, 32:1530–1538.
Baker, M. RNA interference: microRNAs as biomarkers. Nature 2010, 464:1227.
Li, XY, Luo, QF, Wei, CK, Li, DF, Li, J, Fang, L. MiRNA‐107 inhibits proliferation and migration by targeting CDK8 in breast cancer. Int J Clin Exp Med 2014, 7:32–40.
Shimono, Y, Zabala, M, Cho, RW, Lobo, N, Dalerba, P, Qian, D, Diehn, M, Liu, H, Panula, SP, Chiao, E, et al. Downregulation of miRNA‐200c links breast cancer stem cells with normal stem cells. Cell 2009, 138:592–603.
Valastyan, S, Reinhardt, F, Benaich, N, Calogrias, D, Szasz, AM, Wang, ZC, Brock, JE, Richardson, AL, Weinberg, RA. A pleiotropically acting microRNA, miR‐31, inhibits breast cancer metastasis. Cell 2009, 137:1032–1046.
Yu, F, Yao, H, Zhu, P, Zhang, X, Pan, Q, Gong, C, Huang, Y, Hu, X, Su, F, Lieberman, J, et al. let‐7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109–1123.
Dvinge, H, Git, A, Graf, S, Salmon‐Divon, M, Curtis, C, Sottoriva, A, Zhao, Y, Hirst, M, Armisen, J, Miska, EA, et al. The shaping and functional consequences of the microRNA landscape in breast cancer. Nature 2013, 497:378–382.
Ma, L, Teruya‐Feldstein, J, Weinberg, RA. Tumour invasion and metastasis initiated by microRNA‐10b in breast cancer. Nature 2007, 449:682–688.
Tavazoie, SF, Alarcon, C, Oskarsson, T, Padua, D, Wang, Q, Bos, PD, Gerald, WL, Massague, J. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451:147–152.
Bergamaschi, A, Katzenellenbogen, BS. Tamoxifen downregulation of miR‐451 increases 14‐3‐3ζ and promotes breast cancer cell survival and endocrine resistance. Oncogene 2012, 31:39–47.
Hwang‐Verslues, WW, Chang, PH, Wei, PC, Yang, CY, Huang, CK, Kuo, WH, Shew, JY, Chang, KJ, Lee, EY, Lee, WH. miR‐495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E‐cadherin and REDD1. Oncogene 2011, 30:2463–2474.
Rao, X, Di Leva, G, Li, M, Fang, F, Devlin, C, Hartman‐Frey, C, Burow, ME, Ivan, M, Croce, CM, Nephew, KP. MicroRNA‐221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways. Oncogene 2011, 30:1082–1097.
Bockhorn, J, Dalton, R, Nwachukwu, C, Huang, S, Prat, A, Yee, K, Chang, YF, Huo, D, Wen, Y, Swanson, KE, et al. MicroRNA‐30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL‐11. Nat Commun 2013, 4:1393.
Ouyang, M, Li, Y, Ye, S, Ma, J, Lu, L, Lv, W, Chang, G, Li, X, Li, Q, Wang, S, et al. MicroRNA profiling implies new markers of chemoresistance of triple‐negative breast cancer. PLoS One 2014, 9:e96228.
Wang, HJ, Guo, YQ, Tan, G, Dong, L, Cheng, L, Li, KJ, Wang, ZY, Luo, HF. miR‐125b regulates side population in breast cancer and confers a chemoresistant phenotype. J Cell Biochem 2013, 114:2248–2257.
Liang, Z, Wu, H, Xia, J, Li, Y, Zhang, Y, Huang, K, Wagar, N, Yoon, Y, Cho, HT, Scala, S, et al. Involvement of miR‐326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance‐associated protein 1. Biochem Pharmacol 2010, 79:817–824.
Zhu, Y, Yu, F, Jiao, Y, Feng, J, Tang, W, Yao, H, Gong, C, Chen, J, Su, F, Zhang, Y, et al. Reduced miR‐128 in breast tumor‐initiating cells induces chemotherapeutic resistance via Bmi‐1 and ABCC5. Clin Cancer Res 2011, 17:7105–7115.
Bourguignon, LY, Spevak, CC, Wong, G, Xia, W, Gilad, E. Hyaluronan‐CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA‐21, leading to down‐regulation of the tumor suppressor protein PDCD4, anti‐apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 2009, 284:26533–26546.
Huang, X, Taeb, S, Jahangiri, S, Emmenegger, U, Tran, E, Bruce, J, Mesci, A, Korpela, E, Vesprini, D, Wong, CS, et al. miRNA‐95 mediates radioresistance in tumors by targeting the sphingolipid phosphatase SGPP1. Cancer Res 2013, 73:6972–6986.
Liang, Z, Ahn, J, Guo, D, Votaw, JR, Shim, H. MicroRNA‐302 replacement therapy sensitizes breast cancer cells to ionizing radiation. Pharm Res 2013, 30:1008–1016.
Wang, L, Yuan, C, Lv, K, Xie, S, Fu, P, Liu, X, Chen, Y, Qin, C, Deng, W, Hu, W. Lin28 mediates radiation resistance of breast cancer cells via regulation of caspase, H2A.X and Let‐7 signaling. PLoS One 2013, 8:e67373.
Anastasov, N, Hofig, I, Vasconcellos, IG, Rappl, K, Braselmann, H, Ludyga, N, Auer, G, Aubele, M, Atkinson, MJ. Radiation resistance due to high expression of miR‐21 and G2/M checkpoint arrest in breast cancer cells. Radiat Oncol 2012, 7:206.
Lee, KM, Choi, EJ, Kim, IA. microRNA‐7 increases radiosensitivity of human cancer cells with activated EGFR‐associated signaling. Radiother Oncol 2011, 101:171–176.
Lin, J, Liu, C, Gao, F, Mitchel, RE, Zhao, L, Yang, Y, Lei, J, Cai, J. miR‐200c enhances radiosensitivity of human breast cancer cells. J Cell Biochem 2013, 114:606–615.
Cittelly, DM, Das, PM, Spoelstra, NS, Edgerton, SM, Richer, JK, Thor, AD, Jones, FE. Downregulation of miR‐342 is associated with tamoxifen resistant breast tumors. Mol Cancer 2010, 9:317.
Ward, A, Balwierz, A, Zhang, JD, Kublbeck, M, Pawitan, Y, Hielscher, T, Wiemann, S, Sahin, O. Re‐expression of microRNA‐375 reverses both tamoxifen resistance and accompanying EMT‐like properties in breast cancer. Oncogene 2013, 32:1173–1182.
Pogribny, IP, Filkowski, JN, Tryndyak, VP, Golubov, A, Shpyleva, SI, Kovalchuk, O. Alterations of microRNAs and their targets are associated with acquired resistance of MCF‐7 breast cancer cells to cisplatin. Int J Cancer 2010, 127:1785–1794.
Tryndyak, VP, Beland, FA, Pogribny, IP. E‐cadherin transcriptional down‐regulation by epigenetic and microRNA‐200 family alterations is related to mesenchymal and drug‐resistant phenotypes in human breast cancer cells. Int J Cancer 2010, 126:2575–2583.
Bao, L, Hazari, S, Mehra, S, Kaushal, D, Moroz, K, Dash, S. Increased expression of P‐glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR‐298. Am J Pathol 2012, 180:2490–2503.
Zhong, S, Li, W, Chen, Z, Xu, J, Zhao, J. MiR‐222 and miR‐29a contribute to the drug‐resistance of breast cancer cells. Gene 2013, 531:8–14.
Zhou, M, Liu, Z, Zhao, Y, Ding, Y, Liu, H, Xi, Y, Xiong, W, Li, G, Lu, J, Fodstad, O, et al. MicroRNA‐125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro‐apoptotic Bcl‐2 antagonist killer 1 (Bak1) expression. J Biol Chem 2010, 285:21496–21507.
Wang, H, Tan, G, Dong, L, Cheng, L, Li, K, Wang, Z, Luo, H. Circulating MiR‐125b as a marker predicting chemoresistance in breast cancer. PLoS One 2012, 7:e34210.
Kastl, L, Brown, I, Schofield, AC. miRNA‐34a is associated with docetaxel resistance in human breast cancer cells. Breast Cancer Res Treat 2012, 131:445–454.
Pan, YZ, Morris, ME, Yu, AM. MicroRNA‐328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 2009, 75:1374–1379.
Yamamoto, Y, Yoshioka, Y, Minoura, K, Takahashi, RU, Takeshita, F, Taya, T, Horii, R, Fukuoka, Y, Kato, T, Kosaka, N, et al. An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug‐resistance in human breast cancer cells. Mol Cancer 2011, 10:135.
Kong, W, He, L, Coppola, M, Guo, J, Esposito, NN, Coppola, D, Cheng, JQ. MicroRNA‐155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 2010, 285:17869–17879.
Liang, Z, Li, Y, Huang, K, Wagar, N, Shim, H. Regulation of miR‐19 to breast cancer chemoresistance through targeting PTEN. Pharm Res 2011, 28:3091–3100.
Shi, W, Gerster, K, Alajez, NM, Tsang, J, Waldron, L, Pintilie, M, Hui, AB, Sykes, J, P`ng, C, Miller, N, et al. MicroRNA‐301 mediates proliferation and invasion in human breast cancer. Cancer Res 2011, 71:2926–2937.
Gong, C, Yao, Y, Wang, Y, Liu, B, Wu, W, Chen, J, Su, F, Yao, H, Song, E. Up‐regulation of miR‐21 mediates resistance to trastuzumab therapy for breast cancer. J Biol Chem 2011, 286:19127–19137.
Wang, Z, Han, J, Cui, Y, Zhou, X, Fan, K. miRNA‐21 inhibition enhances RANTES and IP‐10 release in MCF‐7 via PIAS3 and STAT3 signalling and causes increased lymphocyte migration. Biochem Biophys Res Commun 2013, 439:384–389.
Zhi, F, Dong, H, Jia, X, Guo, W, Lu, H, Yang, Y, Ju, H, Zhang, X, Hu, Y. Functionalized graphene oxide mediated adriamycin delivery and miR‐21 gene silencing to overcome tumor multidrug resistance in vitro. PLoS One 2013, 8:e60034.
Li, L, Luo, J, Wang, B, Wang, D, Xie, X, Yuan, L, Guo, J, Xi, S, Gao, J, Lin, X, et al. Microrna‐124 targets flotillin‐1 to regulate proliferation and migration in breast cancer. Mol Cancer 2013, 12:163.
Chen, D, Sun, Y, Wei, Y, Zhang, P, Rezaeian, AH, Teruya‐Feldstein, J, Gupta, S, Liang, H, Lin, HK, Hung, MC, et al. LIFR is a breast cancer metastasis suppressor upstream of the Hippo‐YAP pathway and a prognostic marker. Nat Med 2012, 18:1511–1517.
Song, SJ, Poliseno, L, Song, MS, Ala, U, Webster, K, Ng, C, Beringer, G, Brikbak, NJ, Yuan, X, Cantley, LC, et al. MicroRNA‐antagonism regulates breast cancer stemness and metastasis via TET‐family‐dependent chromatin remodeling. Cell 2013, 154:311–324.
Ma, F, Zhang, J, Zhong, L, Wang, L, Liu, Y, Wang, Y, Peng, L, Guo, B. Upregulated microRNA‐301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β‐catenin signaling. Gene 2014, 535:191–197.